3 Bargain Stocks Worth Buying at These 52-Week Lows

InvestorPlace2023-02-26

Finding stocks trading at 52-week lows can be a profitable strategy for risk-tolerant traders.TFF Pharmaceuticals (TFFP): If this clinical-stage biopharma company can find a partner before it runs out...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

hwhw123
2023-02-27
hwhw123
K
Worpeng2002
2023-02-27
Worpeng2002
Ok
andrew123
2023-02-27
andrew123
Like
Seah CL
2023-02-27
Seah CL
K
LionKingAir
2023-02-27
LionKingAir
Ok
NPC69
2023-02-26
NPC69
K

Leave a comment

623

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2314104357?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-02-26 10:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2314104357","market":"us","top_or_hot":-1,"title":"3 Bargain Stocks Worth Buying at These 52-Week Lows","media":"InvestorPlace","content":"<div>\n<p>Finding stocks trading at 52-week lows can be a profitable strategy for risk-tolerant traders.TFF Pharmaceuticals (TFFP): If this clinical-stage biopharma company can find a partner before it runs out...</p>\n\n<a href=\"https://investorplace.com/2023/02/3-bargain-stocks-worth-buying-at-these-52-week-lows/\">Source Link</a>\n\n</div>\n","source":"investorplace","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Bargain Stocks Worth Buying at These 52-Week Lows</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Bargain Stocks Worth Buying at These 52-Week Lows\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-02-26 10:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2023/02/3-bargain-stocks-worth-buying-at-these-52-week-lows/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Finding stocks trading at 52-week lows can be a profitable strategy for risk-tolerant traders.TFF Pharmaceuticals (TFFP): If this clinical-stage biopharma company can find a partner before it runs out...</p>\n\n<a href=\"https://investorplace.com/2023/02/3-bargain-stocks-worth-buying-at-these-52-week-lows/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TQQQ","symbol_name":"纳指三倍做多ETF","start_time":0,"source_url":"https://investorplace.com/2023/02/3-bargain-stocks-worth-buying-at-these-52-week-lows/","article_id":"2314104357","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2314104357","pubTimestamp":1677379035,"columns":[],"sourceInfo":{"source_id":"investorplace","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Finding stocks trading at 52-week lows can be a profitable strategy for risk-tolerant traders.TFF Ph","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TQQQ":"纳指三倍做多ETF","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","COST":"好市多","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","PSQ":"纳指反向ETF","BK4212":"包装食品与肉类","QLD":"纳指两倍做多ETF","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","BK4585":"ETF&股票定投概念","RGF":"The Real Good Food Company, Inc.","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4533":"AQR资本管理(全球第二大对冲基金)","STKH":"Steakholder Foods","BK4007":"制药","LU0079474960.USD":"联博美国增长基金A","LU2360032135.SGD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (SGDHDG) INC","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","SQQQ":"纳指三倍做空ETF","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU2125154778.USD":"ALLSPRING GLOBAL EQUITY ENHANCED INCOME \"A\" (USD) INC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","BK4588":"碎股","QQQ":"纳指100ETF","BK4550":"红杉资本持仓","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H",".IXIC":"NASDAQ Composite","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU2125154935.USD":"ALLSPRING (LUX) WF GLOBAL EQUITY ENHANCED INCOME \"I\" (USD) INC","TFFP":"TFF Pharmaceuticals","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","QID":"纳指两倍做空ETF","BK4155":"大卖场与超市","BK4581":"高盛持仓","BK4504":"桥水持仓"},"translate_title":"3只值得在52周低点买入的廉价股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COST":1,"TFFP":1,"STKH":1,"RGF":1,".IXIC":0.76,"SQQQ":0.6,"QQQ":0.6,"QLD":0.6,"QID":0.6,"PSQ":0.6,"TQQQ":0.6,"MNQmain":0.6,"NQmain":0.6},"content_text":"Finding stocks trading at 52-week lows can be a profitable strategy for risk-tolerant traders.TFF Pharmaceuticals (TFFP): If this clinical-stage biopharma company can find a partner before it runs out of cash, its runway could be long. Steakholder Foods (STKH): The company has multiple patents aimed at innovation and disruption in food. Real Good Food (RGF): Their line of healthy frozen food is competing in the right channels.Source: ShutterstockWho doesn’t love a bargain? We look for deals in many places. And when it comes to investing, we look for bargain stocks. This can mean different things to different investors. Some investors will consider a stock a bargain if it’s undervalued.But this is no ordinary market. You’ve heard of hard landings and soft landings. But right now, there are growing concerns about stagflation which is the scenario of no immediate landing. That would be bad news for even the “safest” of stocks. That’s why it may be time to try something new.In coming up with the stocks for this article, I’m looking at stocks that are trading at or near 52-week lows and have some analyst support.While no strategy is foolproof, finding stocks trading at 52-week lows in a market like this can make for a profitable trade. If nothing else, these bargain stocks aren’t overvalued. And if they have the support of an analyst or a handful of analysts, it can signal that the 52-week low will serve as support.With that in mind, every stock on this list is a penny stock. Penny stocks carry a tremendous risk and the possibility of an outsized reward. And while each stock has a story that could send it much higher, each of these bargain stocks may never deliver on its promise.TFFPTFF Pharmaceuticals$0.73STKHSteakholder Foods$0.80RGFReal Good Food$4.23TFF Pharmaceuticals (TFFP) Source: Hernan E. Schmidt / Shutterstock.comTFF Pharmaceuticals (NASDAQ:TFFP) is a clinical-stage biopharmaceutical company that has developed its proprietary Thin Film Freezing technology. The technology attempts to “transform medicines into elegant and potent dry powders for better efficacy, safety, and stability.”Although the company does not have a product through clinical trials, there’s no evidence that the technology doesn’t work. But to date, the company has not found a partner that would provide the necessary funding.And, like all biotechs, that’s the real issue. The company said in December that it was capitalized through 2023. But they won’t have a product through clinical trials until 2024. So that could mean another round of share dilution unless they find a partner.One thing that may help that process is that the company has appointed an interim CEO. The leadership of former CEO Glenn Mattes was called into question by shareholders.Analysts do not widely cover the company. But it does have the support of the analysts that do cover the stock. It has a consensus buy rating and a price target of $20, a gain of over 2,900%.Steakholder Foods (STKH) Source: barmalini/Shutterstock.comSteakholder Foods (NASDAQ:STKH) was formerly known as MeaTech 3D. The new name, however, fits into their mission of being a leader in the emerging field of structured or cultivated meat. And the play on the word “stakeholder” can’t hurt when you’re a company bound to be looked upon favorably by investors who prioritize ESG (environmental, sustainability, and corporate governance) standards.The company is using 3D bioprinting to make meat from animal cells. The goal is to feed a growing population while protecting the environment and the welfare of animals. The company has applied for 18 patents and has received and been granted four.Numerous analysts suggest cultivated meat will have a large addressable market between now and 2050. That makes STKH stock a long-term play. However, as the company’s recent $6.5 million securities offering reminds investors, this will still be volatile.Real Good Food (RGF) Source: shutterstock.com/ampersandphotoThe last of our bargain stocks is another play on the future of food is The Real Good Food Company (NASDAQ:RGF). But this company is generating revenue today. And the company’s gluten-free and grain-free products are in several notable channels, such as Costco (NASDAQ:COST) and Sam’s Club.The marketing message is that the company offers products that have more protein with fewer carbs and without sacrificing taste.The company was profitable GAAP-based in two out of the last three quarters. But the company went from a GAAP profit of 49 cents a share to a loss of 51 cents a share in the previous quarter. And with revenue jumping over 20% sequentially, the company may have difficulty passing inflation-related costs along to its customers.Revenue and earnings are expected to grow at 38% and 34% in the next five years. Eight analysts give RGF stock a $14.28 mean price target. That’s a gain of over 230% from its current price.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9957401044,"gmtCreate":1677462895388,"gmtModify":1677463106385,"author":{"id":"3578710390898389","authorId":"3578710390898389","name":"hwhw123","avatar":"https://static.tigerbbs.com/d8403e7374bdcb179a82aff3b6d9338e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578710390898389","authorIdStr":"3578710390898389"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957401044","repostId":2314104357,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9957578876,"gmtCreate":1677458641495,"gmtModify":1677458644804,"author":{"id":"3582000520700468","authorId":"3582000520700468","name":"Worpeng2002","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582000520700468","authorIdStr":"3582000520700468"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957578876","repostId":2314104357,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9957541926,"gmtCreate":1677452645965,"gmtModify":1677452647776,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f2a1eaba26272212d42018e60e78b422","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"idStr":"3576260758860416","authorIdStr":"3576260758860416"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957541926","repostId":2314104357,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9957556269,"gmtCreate":1677447134852,"gmtModify":1677447138213,"author":{"id":"4102135564535180","authorId":"4102135564535180","name":"Seah CL","avatar":"https://community-static.tradeup.com/news/970bca7b04e85a42a2c8eabed7ec96d0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4102135564535180","authorIdStr":"4102135564535180"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957556269","repostId":2314104357,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9957550841,"gmtCreate":1677427584084,"gmtModify":1677427587920,"author":{"id":"3582891836402828","authorId":"3582891836402828","name":"LionKingAir","avatar":"https://static.tigerbbs.com/94f60573baa578de19304c643193dad9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582891836402828","authorIdStr":"3582891836402828"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957550841","repostId":2314104357,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9957523273,"gmtCreate":1677419595992,"gmtModify":1677419599530,"author":{"id":"3584779133668268","authorId":"3584779133668268","name":"NPC69","avatar":"https://static.tigerbbs.com/47e7ac55312ae8dd1c9e7cb92adad089","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3584779133668268","authorIdStr":"3584779133668268"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9957523273","repostId":2314104357,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":623,"commentSize":9,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2314104357"}